EditorialEditorial
Arthritis Gene Therapy Trials Reach Phase II
CHRISTOPHER EVANS
The Journal of Rheumatology April 2010, 37 (4) 683-685; DOI: https://doi.org/10.3899/jrheum.100055
CHRISTOPHER EVANS
REFERENCES
- 1.↵
- 2.↵
- 3.↵
- 4.↵
- 5.↵
- Evans CH,
- Robbins PD,
- Ghivizzani SC,
- Wasko MC,
- Tomaino MM,
- Kang R,
- et al.
- 6.↵
- Mease PJ,
- Hobbs K,
- Chalmers A,
- El-Gabalawy H,
- Bookman A,
- Keystone E,
- et al.
- 7.↵
- 8.↵
- Mease PJ,
- Wei N,
- Fudman EJ,
- Kivitz AJ,
- Schechtman J,
- Trapp RG,
- et al.
- 9.↵
- Ghivizzani SC,
- Lechman ER,
- Kang R,
- Tio C,
- Kolls J,
- Evans CH,
- et al.
- 10.↵
- 11.↵
- 12.↵
- 13.↵
- 14.↵
- 15.↵
- 16.↵
- 17.↵
- 18.↵
- 19.↵
- 20.↵
- 21.↵
- Kolata G
- 22.↵
In this issue
The Journal of Rheumatology
Vol. 37, Issue 4
1 Apr 2010
Arthritis Gene Therapy Trials Reach Phase II
CHRISTOPHER EVANS
The Journal of Rheumatology Apr 2010, 37 (4) 683-685; DOI: 10.3899/jrheum.100055